350 related articles for article (PubMed ID: 34494884)
1. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection
Cartwright HN; Barbeau DJ; McElroy AK
mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884
[TBL] [Abstract][Full Text] [Related]
2. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
3. Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
Gutjahr B; Keller M; Rissmann M; von Arnim F; Jäckel S; Reiche S; Ulrich R; Groschup MH; Eiden M
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008143. PubMed ID: 32160203
[TBL] [Abstract][Full Text] [Related]
4. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
5. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus.
Wang Q; Ma T; Wu Y; Chen Z; Zeng H; Tong Z; Gao F; Qi J; Zhao Z; Chai Y; Yang H; Wong G; Bi Y; Wu L; Shi R; Yang M; Song J; Jiang H; An Z; Wang J; Yilma TD; Shi Y; Liu WJ; Liang M; Qin C; Gao GF; Yan J
Nat Microbiol; 2019 Jul; 4(7):1231-1241. PubMed ID: 30936489
[TBL] [Abstract][Full Text] [Related]
6. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
Bhardwaj N; Heise MT; Ross TM
PLoS Negl Trop Dis; 2010 Jun; 4(6):e725. PubMed ID: 20582312
[TBL] [Abstract][Full Text] [Related]
8. Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.
Jäckel S; Eiden M; Dauber M; Balkema-Buschmann A; Brun A; Groschup MH
Arch Virol; 2014 Mar; 159(3):535-46. PubMed ID: 24100475
[TBL] [Abstract][Full Text] [Related]
9. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
[TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
Barbeau DJ; Cartwright HN; Harmon JR; Spengler JR; Spiropoulou CF; Sidney J; Sette A; McElroy AK
J Virol; 2021 Nov; 95(23):e0150621. PubMed ID: 34495703
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.
Papin JF; Verardi PH; Jones LA; Monge-Navarro F; Brault AC; Holbrook MR; Worthy MN; Freiberg AN; Yilma TD
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14926-31. PubMed ID: 21873194
[TBL] [Abstract][Full Text] [Related]
12. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
13.
Ma J; Chen R; Huang W; Nie J; Liu Q; Wang Y; Yang X
Hum Vaccin Immunother; 2019; 15(10):2286-2294. PubMed ID: 31170027
[TBL] [Abstract][Full Text] [Related]
14. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.
Chapman NS; Zhao H; Kose N; Westover JB; Kalveram B; Bombardi R; Rodriguez J; Sutton R; Genualdi J; LaBeaud AD; Mutuku FM; Pittman PR; Freiberg AN; Gowen BB; Fremont DH; Crowe JE
Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33782133
[TBL] [Abstract][Full Text] [Related]
15. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
Dodd KA; Bird BH; Metcalfe MG; Nichol ST; Albariño CG
J Virol; 2012 Apr; 86(8):4204-12. PubMed ID: 22345465
[TBL] [Abstract][Full Text] [Related]
16. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
Soi RK; Rurangirwa FR; McGuire TC; Rwambo PM; DeMartini JC; Crawford TB
Clin Vaccine Immunol; 2010 Dec; 17(12):1842-9. PubMed ID: 20876822
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein.
Hao M; Zhang G; Zhang S; Chen Z; Chi X; Dong Y; Fan P; Liu Y; Chen Y; Song X; Liu S; Yu C; Li J; Xia X
Viruses; 2020 Feb; 12(3):. PubMed ID: 32120864
[TBL] [Abstract][Full Text] [Related]
18. Equine immunoglobulin F(ab')
Zhao Y; Zheng X; He S; Li Y; Wang W; Gai W; Wong G; Wang H; Yan F; Xue F; Feng N; Wang T; Gao Y; Yang S; Qiu X; Xia X
Int Immunopharmacol; 2018 Nov; 64():217-222. PubMed ID: 30199846
[TBL] [Abstract][Full Text] [Related]
19. Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.
Dodd KA; McElroy AK; Jones ME; Nichol ST; Spiropoulou CF
J Virol; 2013 Jun; 87(11):6161-71. PubMed ID: 23536675
[TBL] [Abstract][Full Text] [Related]
20. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.
Harmon JR; Spengler JR; Coleman-McCray JD; Nichol ST; Spiropoulou CF; McElroy AK
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
